News

Enhancing the European R&I system – update call topic HORIZON-WIDERA-2024-ERA-01-05

Published on
| 2 years ago
Programmes
  • Enhancing EU R&I

The European Commission has cancelled the topic HORIZON-WIDERA-2024-ERA-01-05: Experimentation and exchange of good practices for value creation. The next amendment of the Work Programme will re-introduce the topic with an updated description to be funded under a call in fall 2024.

Source: European Commission Funding and tender portal

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2062 articles available Browse all news
  • EIT
  • New European Bauhaus

Catalyse NEB Open Call 2027 launched

The New European Bauhaus Community of EIT (European Institute of Innovation and Technology) has opened the Catalyse NEB Open Call 2027. The call concerns its accelerator programme for start-ups and is linked to the New European Bauhaus. The programme aims to support 20 for-profit start-ups incorporated after 1 January 2022 in an eligible country....

Read more
  • Climate, Energy, Mobility
  • EIT

2027 SME Market Expansion Call of EIT Urban Mobility

EIT Urban Mobility has opened the SME Market Expansion Open Call 2027. The call is designed for small and medium-sized enterprises that want to expand proven urban mobility solutions into new markets, regions or sectors. Applications must be supported by an end client, either a public or private entity, that is committed to testing and...

Read more
  • ERC

First edition of ERC Success Stories from Widening Countries

The network of National Contact Points (NCPs) for the European Research Council (ERC), mERCury, has recently published the first edition of the ERC Success Stories from Widening countries. The collection features seven ERC grantees from Malta, Croatia, Romania, Slovenia, Latvia, Greece and Türkiye who have received Starting, Consolidator,...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.